首页
400-620-6333
切换导航
搜索
基本描述
| 英文名称 | Mal-PEG8-Val-Cit-PAB-MMAE |
|---|---|
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
Mal-PEG8-Val-Cit-PAB-MMAE is a precursor of antibody drug conjugate. It contains a maleimide-PEG8 spacer, a protease-sensitive Val-Cit dipeptide, a PABC linker and a MMAE payload. The MMAE is a synthetic antineoplastic agent. It can be attached to a monoclonal antibody (MAB) which directs it toward cancer cells. |
名称和标识符
| 分子量 | 1627 |
|---|
附件产品
-
SPDP-Val-Cit-PAB-PNP, 98%, 5mg￥6,720.90
-
endo-BCN-PEG4-Val-Cit-PAB-MMAE, 98%, 5mg￥18,690.90
-
Boc-Val-Cit-PAB, 95%, 250mg￥5,880.90
-
Mal-amido-PEG2-Val-Cit-PAB-PNP, 98%, 50mg￥11,340.90
-
Azido-PEG3-Val-Cit-PAB-OH, 96%, 100mg￥7,350.90
产品问答
产品问答
上海阿拉丁生化科技股份有限公司
? 2016 ALADDIN-E.COM . 版权所有,未经授权禁止拷贝本站资料,如有违反,将追究法律责任
危险品化学品经营许可证（带存储）